|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
Vollmers, Sarah; Lobermeyer, Annabelle; Niehrs, Annika; Fittje, Pia; Indenbirken, Daniela; Nakel, Jacqueline; Virdi, Sanamjeet; Brias, Sebastien; Trenkner, Timo; Sauer, Gabriel; Peine, Sven; Behrens, Georg M. N.; Lehmann, Clara; Meurer, Anja; Pauli, Ramona; Postel, Nils; Roider, Julia; Scholten, Stefan; Spinner, Christoph D.; Stephan, Christoph; Wolf, Eva; Wyen, Christoph; Richert, Laura; Norman, Paul J.; Sauter, Juergen; Schmidt, Alexander H.; Hoelzemer, Angelique; Altfeld, Marcus und Koerner, Christian
(2022):
Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.
In: Frontiers in Immunology, Bd. 13, 922252
2020
Adland, Emily; Millar, Jane; Bengu, Nomonde; Münchhoff, Maximilian; Fillis, Rowena; Sprenger, Kenneth; Ntlantsana, Vuyokasi; Roider, Julia; Vieira, Vinicius; Govender, Katya; Adamson, John; Nxele, Nelisiwe; Ochsenbauer, Christina; Kappes, John; Mori, Luisa; Lobenstein, Jeroen van; Graza, Yeney; Chinniah, Kogielambal; Kapongo, Constant; Bhoola, Roopesh; Krishna, Malini; Matthews, Philippa C.; Penya Poderos, Ruth; Colomer Lluch, Marta; Carmen Puertas, Mari; Prado, Julia G.; McKerrow, Neil; Archary, Moherndran; Ndung'u, Thumbi; Groll, Andreas; Jooste, Pieter; Martinez-Picado, Javier; Altfeld, Marcus und Goulder, Philip
(2020):
Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection.
In: Nature Communications, Bd. 11, Nr. 1
[PDF, 1MB]
2017
Rechtien, Anne; Richert, Laura; Lorenzo, Hadrien; Martrus, Gloria; Hejblum, Boris; Dahlke, Christine; Kasonta, Rahel; Zinser, Madeleine; Stubbe, Hans; Matschl, Urte; Lohse, Ansgar; Kraehling, Verena; Eickmann, Markus; Becker, Stephan; Thiebaut, Rodolphe; Altfeld, Marcus und Addo, Marylyn
(2017):
Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.
In: Cell Reports, Bd. 20, Nr. 9: S. 2251-2261